Abiopharma

🔍 Newby Matt (Executive)

Company: EAGLE MATERIALS INC (EXP)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Sold 907 shares of Common Stock at $181.5 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: false | shares_owned_after: 19,129.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 600 shares of Common Stock at $181.5 per share (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: false | shares_owned_after: 19,729.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 239 shares of Common Stock at $181.5 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: false | shares_owned_after: 19,490.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 600 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: false | shares_owned_after: 597.07 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: In accordance with the issuer's 2023 Equity Incentive Plan, this price represents the closing price per share of Common Stock on the previous trading day.
• F2: 907 shares were withheld by the issuer to satisfy income tax withholding requirements related to the lapsing of restrictions on (a) 749 shares of restricted stock awarded to the reporting person on 5/23/23 (Form 4 filed 5/25/23); and (b) 1,525 shares of restricted stock awarded to the reporting person on 5/19/22 (Form 3 filed 6/6/22 and Form 4 filed 5/10/23). Because the reporting person's restricted holdings have been included in the direct ownership of Common Stock disclosed by the reporting person, the reporting person's direct ownership of Common Stock has been reduced by 907 shares to reflect this tax withholding.
• F3: Each restricted stock unit represents a contingent right to receive one share of EXP common stock.
• F4: On May 24, 2024, the reporting person was granted 1,784 restricted stock units, vesting ratably in three installments on the first anniverary of the date of award; on March 31, 2026; and on March 31, 2027. Upon vesting, any related dividend-equivalent RSUs are also vested at that time.